,Keyword_1,frequency,Keyword_2,degreee
0,prenatal diagnosis,24,prenatal diagnosis,65
1,down syndrome,12,down syndrome,36
2,cell-free fetal dna,10,aneuploidy,25
3,aneuploidy,8,cell-free fetal dna,24
4,fetal dna,8,fetal dna,22
5,cell-free dna,7,dna,21
6,next-generation sequencing,6,nipt,18
7,noninvasive prenatal testing,6,cell-free dna,18
8,nipt,5,prenatal,18
9,noninvasive,5,fetal cells,16
10,dna,5,noninvasive prenatal testing,15
11,prenatal,5,noninvasive,15
12,noninvasive prenatal diagnosis,5,next-generation sequencing,14
13,next-generation,4,next-generation,10
14,next generation sequencing,4,fetal aneuploidy,10
15,massively parallel sequencing,4,noninvasive prenatal diagnosis,10
16,fetal cells,4,non-invasive,9
17,fetal aneuploidy,4,next generation sequencing,9
18,maternal plasma,4,massively parallel sequencing,9
19,dna methylation,3,maternal plasma,9
20,non-invasive prenatal,3,treatment,8
21,noninvasive prenatal,3,rna,8
22,non-invasive,3,dna methylation,7
23,non-invasive prenatal testing,3,non-invasive prenatal,7
24,polymorphisms,3,transplant,7
25,treatment,3,genetics,6
26,fetal dna in maternal plasma,3,noninvasive prenatal,6
27,circulating nucleic acids,3,non-invasive prenatal testing,6
28,genetics,2,maternal plasma dna,6
29,thalassemia,2,maternal,6
30,noninvasive prenatal test,2,circulating nucleic acids,6
31,monogenic diseases,2,thalassemia,5
32,maternal plasma dna,2,noninvasive prenatal test,5
33,digital pcr,2,monogenic diseases,5
34,maternal,2,polymorphisms,5
35,circulating fetal dna,2,gene,5
36,plasma dna,2,metabolism,5
37,transplant,2,rare,5
38,trisomy 21,2,villus,5
39,rna,2,digital pcr,5
40,circulating cell-free fetal dna,2,depth of coverage,5
41,non-invasive prenatal diagnosis,2,ngs,5
42,beta-thalassemia,2,whole genome,5
43,gene mutation,2,plasma dna,5
44,calves,1,genome,5
45,prenatal stress,1,exome,5
46,prenatal exome,1,mendelian,5
47,variants of unknown clinical significance,1,cancer,5
48,phenotyping,1,trisomy 21,5
49,cell-free dna sequencing,1,qf-pcr,5
50,copy-number variant,1,chromosome x aneuploidies,5
51,incidental finding,1,amelogenin,5
52,cell free fetal dna,1,nucleic,5
53,monogenic disorders,1,beta-thalassemia,5
54,cell-free deoxyribonucleic acid (cfdna),1,gene mutation,5
55,fetus,1,trisomy,4
56,genetic diagnosis,1,screening,4
57,hemophilia b,1,chromosomes,4
58,karyomapping,1,fragmented dna,4
59,preimplantation genetic,1,genetic analysis,4
60,infant,1,intact,4
61,premature,1,chromosome abnormality,4
62,gastrointestinal microbiome,1,microarray,4
63,anti-bacterial agents,1,genetic,4
64,genomics,1,fetal dna in maternal plasma,4
65,expanded carrier screening,1,fetal diagnosis,4
66,cell free dna,1,first trimester,4
67,chromosomal,1,circulating fetal dna,4
68,fetal overgrowth,1,genetic counselling,4
69,gpc3,1,single gene disorders,4
70,prenatal symptoms,1,general,4
71,simpson-golabi-behmel,1,circulating cell-free fetal dna,4
72,copy number variation,1,nucleic acids and proteins,4
73,prenatal paternity testing,1,single gene,4
74,massively parallel,1,cytogenetics,4
75,target region capture,1,array cgh,4
76,massively,1,snp arrays,4
77,high-throughput sequencing,1,dna sequencing,4
78,sex chromosomal aneuploidies,1,structural,4
79,choroideremia,1,cell free fetal dna,3
80,dna mutation,1,cell-free deoxyribonucleic acid (cfdna),3
81,aneuploidies,1,fetus,3
82,circulating cell-free dna,1,genetic diagnosis,3
83,targeted sequencing,1,hemophilia b,3
84,massive,1,karyomapping,3
85,chromosomal microarray analysis,1,preimplantation genetic,3
86,noninvasive prenatal screening,1,infant,3
87,case reports,1,premature,3
88,obstetrics,1,gastrointestinal microbiome,3
89,prenatal care,1,anti-bacterial agents,3
90,"cell-free dna, (cfdna)",1,genomics,3
91,"cell-free fetal dna, (cffdna)",1,expanded carrier screening,3
92,copy number,1,cell free dna,3
93,gene,1,chromosomal,3
94,metabolism,1,fetal overgrowth,3
95,rare,1,gpc3,3
96,villus,1,prenatal symptoms,3
97,tyrosinemia,1,simpson-golabi-behmel,3
98,fah gene,1,target region capture,3
99,methylome,1,massively,3
100,transcriptome,1,choroideremia,3
101,massive parallel sequencing,1,dna mutation,3
102,bioinformatics analysis,1,targeted sequencing,3
103,trisomy,1,massive,3
104,screening,1,case reports,3
105,chromosomes,1,obstetrics,3
106,aneuploidy screening,1,prenatal care,3
107,massive-parallel dna sequencing,1,tyrosinemia,3
108,array analysis,1,fah gene,3
109,commercialization,1,methylome,3
110,fragmented dna,1,transcriptome,3
111,genetic analysis,1,massive parallel sequencing,3
112,intact,1,amplification-free,3
113,array cgh limitations,1,library preparation,3
114,molecular karyotyping,1,karyotyping,3
115,prenatal cnv-seq,1,sequencing,3
116,amplification-free,1,trisomy 9,3
117,library preparation,1,arpkd,3
118,karyotyping,1,pkhd1,3
119,sequencing,1,compound heterozygous mutation,3
120,trisomy 9,1,size profiling,3
121,chromosome abnormality,1,down,3
122,microarray,1,chromosomal aberrations,3
123,genetic,1,clinical practice,3
124,depth of coverage,1,next generation,3
125,ngs,1,ldr microarray,3
126,whole genome,1,congenital deafness,3
127,arpkd,1,amniocentesis,3
128,pkhd1,1,chorionic villus sampling,3
129,compound heterozygous mutation,1,fetal aneuploidies,3
130,congenital adrenal hyperplasia,1,maternal serum,3
131,haplotype,1,chromosomal abnormalities,3
132,size profiling,1,plasma nucleic acids,3
133,down,1,foetal dna in maternal,3
134,chromosomal aberrations,1,nucleic acids & proteins,3
135,clinical practice,1,maternal serum screening,3
136,next generation,1,hemoglobinopathies,3
137,ldr microarray,1,pyrosequencing,3
138,congenital deafness,1,maternal dna,3
139,whole genome sequencing,1,carrier testing,3
140,massive parallel genomic sequencing,1,non-invasive prenatal diagnosis,3
141,fetal sex,1,chromosomal aneuploidy,3
142,fetal diagnosis,1,monogenic disease,3
143,first trimester,1,hemophilia,3
144,down syndrome screening,1,dna inversions,3
145,chromosomal abnormality,1,is-pcr,3
146,prenatal screening,1,egypt,3
147,cffdna,1,outcome,3
148,chromosomal aneuploidies,1,epigenetic,3
149,amniocentesis,1,polymerase chain reaction,3
150,chorionic villus sampling,1,short tandem,3
151,fetal aneuploidies,1,haemophilia,3
152,maternal serum,1,pregnancy,3
153,fetal whole genome recovery,1,tuberous sclerosis,3
154,genome,1,rhabdomyoma,3
155,exome,1,hereditary spastic paraplegia,3
156,mendelian,1,hsp,3
157,cancer,1,spg4,3
158,cell free fetal dna in maternal blood,1,beta thalassemia,3
159,chromosomal abnormalities,1,dna maternal contamination,3
160,cell-free dna (cfdna),1,hla ssp-pcr,3
161,plasma nucleic acids,1,eec syndrome,3
162,foetal dna in maternal,1,genodermatosis,3
163,genetic counselling,1,p63 gene mutation,3
164,single gene disorders,1,netherton syndrome,3
165,general,1,spink5,3
166,nucleic acids & proteins,1,serine protease,3
167,maternal serum screening,1,epidermolysis bullosa simplex,3
168,hemoglobinopathies,1,keratin 14,3
169,pyrosequencing,1,mutation,3
170,maternal dna,1,calves,2
171,carrier testing,1,prenatal stress,2
172,nipd,1,prenatal exome,2
173,cell-free fetal nucleic acids,1,variants of unknown clinical significance,2
174,fetal,1,phenotyping,2
175,nucleic acids and proteins,1,cell-free dna sequencing,2
176,single gene,1,copy-number variant,2
177,chromosomal aneuploidy,1,incidental finding,2
178,monogenic disease,1,monogenic disorders,2
179,cytogenetics,1,copy number variation,2
180,array cgh,1,prenatal paternity testing,2
181,snp arrays,1,massively parallel,2
182,dna sequencing,1,high-throughput sequencing,2
183,structural,1,sex chromosomal aneuploidies,2
184,epigenomics,1,aneuploidies,2
185,prevention of chromosome abnormalities,1,circulating cell-free dna,2
186,genetic treatment,1,noninvasive prenatal screening,2
187,real-time pcr,1,"cell-free dna, (cfdna)",2
188,huntington-disease,1,"cell-free fetal dna, (cffdna)",2
189,sex determination,1,copy number,2
190,point,1,bioinformatics analysis,2
191,genetic digital pcr,1,aneuploidy screening,2
192,quantitative-analysis,1,massive-parallel dna sequencing,2
193,qf-pcr,1,array analysis,2
194,chromosome x aneuploidies,1,commercialization,2
195,amelogenin,1,array cgh limitations,2
196,nucleic,1,molecular karyotyping,2
197,hemophilia,1,prenatal cnv-seq,2
198,dna inversions,1,congenital adrenal hyperplasia,2
199,is-pcr,1,haplotype,2
200,fluorescence amplifying slides,1,whole genome sequencing,2
201,solexa sequencing,1,massive parallel genomic sequencing,2
202,egypt,1,fetal sex,2
203,outcome,1,down syndrome screening,2
204,epigenetic,1,chromosomal abnormality,2
205,polymerase chain reaction,1,prenatal screening,2
206,short tandem,1,cffdna,2
207,beta-thalassemia (thal),1,chromosomal aneuploidies,2
208,reverse dot-blot,1,fetal whole genome recovery,2
209,haemophilia,1,cell free fetal dna in maternal blood,2
210,pregnancy,1,cell-free dna (cfdna),2
211,holocarboxylase synthetase,1,nipd,2
212,molecular diagnosis,1,cell-free fetal nucleic acids,2
213,dmd,1,fetal,2
214,carrier analysis,1,epigenomics,2
215,semiquantitative pcr,1,prevention of chromosome abnormalities,2
216,circulating nucleic,1,genetic treatment,2
217,tuberous sclerosis,1,real-time pcr,2
218,rhabdomyoma,1,huntington-disease,2
219,xeroderma pigmentosum group a,1,sex determination,2
220,hereditary spastic paraplegia,1,point,2
221,hsp,1,genetic digital pcr,2
222,spg4,1,solexa sequencing,2
223,mutation analysis,1,beta-thalassemia (thal),2
224,iran,1,reverse dot-blot,2
225,beta thalassemia,1,holocarboxylase synthetase,2
226,dna maternal contamination,1,molecular diagnosis,2
227,hla ssp-pcr,1,dmd,2
228,eec syndrome,1,carrier analysis,2
229,genodermatosis,1,semiquantitative pcr,2
230,p63 gene mutation,1,circulating nucleic,2
231,netherton syndrome,1,xeroderma pigmentosum group a,2
232,spink5,1,mutation analysis,2
233,serine protease,1,iran,2
234,d-bifunctional protein deficiency,1,d-bifunctional protein deficiency,2
235,peroxisomal disorder,1,peroxisomal disorder,2
236,graft rejection,1,graft rejection,2
237,polymerase chain reaction (pcr),1,polymerase chain reaction (pcr),2
238,epidermolysis bullosa simplex,1,primary immunodeficiency,2
239,keratin 14,1,wiskott-aldrich syndrome,2
240,mutation,1,chromosomal microarray analysis,1
241,primary immunodeficiency,1,quantitative-analysis,1
242,wiskott-aldrich syndrome,1,fluorescence amplifying slides,1
